\-\ Texto\\:\\ \ \(0\)\
\-\ in\\ the\\ above\\ patient\\,\\ who\\ additionally\\ has\\ renal\\ failure\\ and\\ heart\\ failure\\,\\ the\\ decision\\ was\\ made\\ to\\ manage\\ the\\ condition\\ medically\\ \\(with\\ intravenous\\ antibiotics\\)\\ rather\\ than\\ surgically\\.\\ \\ in\\ addition\\ to\\ following\\ serum\\ markers\\ for\\ infection\\ \\(c\\-reactive\\ protein\\,\\ erythrocyte\\ sedimentation\\ rate\\)\\,\\ the\\ pet\\ scan\\ was\\ performed\\ to\\ \\‚\\Ä\\úquantify\\‚\\Ä\\ù\\ the\\ intensity\\ of\\ involvement\\,\\ with\\ planned\\ repeat\\ scan\\ 3\\ weeks\\ following\\ antibiotics\\ to\\ assess\\ response\\.\ \(0\)\
\-\ ct\\:\\ june\\ 15\\ \\-\\-\\ 4\\.2\\ cm\\ infrarenal\\ abdominal\\ aortic\\ aneurysm\\ noted\\.\ \(0\)\
\-\ july\\ \\ 18\\ \\‚\\Ä\\ì\\ \\(image\\ at\\ same\\ level\\ as\\ above\\)\\.\\ aaa\\ now\\ measures\\ 4\\.9\\ cm\\ and\\ has\\ surrounding\\,\\ diffuse\\ inflammatory\\ fat\\ stranding\\,\\ with\\ partial\\ indistinctness\\ of\\ the\\ aortic\\ wall\\.\ \(0\)\
\-\ indium\\-111\\ wbc\\ scan\\ \\‚\\Ä\\ì\\	twenty\\-fours\\ hours\\ after\\ iv\\ injection\\ of\\ autologous\\ wbcs\\,\\ whole\\ body\\ planar\\ images\\ were\\ performed\\.\\ \\ intense\\ fusiform\\ radiotracer\\ uptake\\ is\\ present\\ in\\ the\\ region\\ of\\ the\\ abdominal\\ aorta\\.\\ \\ findings\\ were\\ confirmed\\ with\\ hawkeye\\ camera\\ \\(ct\\ \\/\\ spect\\ fusion\\)\\.\\ \\ \ \(0\)\
\-\ \\ \\ \ \(31891\)\
\-\ pet\\ imaging\\-\\	after\\ injection\\ with\\ f\\-18\\ flourodeoxyglucose\\,\\ images\\ show\\ intense\\ increased\\ f\\-18\\ fdg\\ metabolism\\ in\\ the\\ region\\ of\\ the\\ infrarenal\\ abdominal\\ aorta\\ in\\ a\\ ring\\-like\\ configuration\\ \\(suv\\ approx\\.\\ 9\\)\\,\\ with\\ additional\\ region\\ of\\ increased\\ metabolism\\ \\(suv\\ approx\\ 4\\)\\ in\\ region\\ of\\ sigmoid\\,\\ representing\\ either\\ extension\\ of\\ infection\\,\\ post\\-surgical\\ change\\ or\\ residual\\/recurrent\\ tumor\\.\ \(0\)\
\-\ mycotic\\ aneurysm\ \(9\)\
\-\ mycotic\\ aneurysm\\,\\ inflammatory\\ aneurysm\\,\\ leaking\\ aneurysm\ \(2\)\
\-\ status\\ post\\ sigmoid\\ resection\\ \\(for\\ carcinoma\\)\\ in\\ early\\ june\\ 2003\\.\\ discharged\\ from\\ hospital\\ but\\ readmitted\\ 15\\ june\\ for\\ mental\\ status\\ change\\ and\\ intermittent\\ fevers\\.\\ \\ imaging\\ unremarkable\\ for\\ contributory\\ etiology\\ at\\ that\\ time\\.\\ \\ patient\\ improved\\,\\ was\\ discharged\\,\\ but\\ re\\-admitted\\ approx\\.\\ 15\\ july\\ with\\ similar\\ symptoms\\ and\\ sepsis\\,\\ with\\ 4\\/4\\ blood\\ cultures\\ positive\\ for\\ staph\\.\\ aureus\\ sepsis\\.\ \(0\)\
\-\ based\\ on\\ ct\\ appearance\\:\\ \\ mycotic\\ aneurysm\\,\\ inflammatory\\ aneurysm\\,\\ leaking\\ aneurysm\\.\\ \\ \\ combined\\ with\\ the\\ in\\-111\\ wbc\\ scan\\,\\ and\\ with\\ the\\ patient\\‚\\Ä\\ôs\\ know\\ history\\ of\\ sepsis\\,\\ it\\ is\\ highly\\ suspicious\\ for\\ mycotic\\ aneurysm\\.\\ \\ leaking\\ aneurysm\\ would\\ likely\\ be\\ more\\ associated\\ with\\ retroperitoneal\\ hemorrhage\\ and\\ possibly\\ decrease\\ in\\ hb\\/hct\\,\\ neither\\ of\\ which\\ were\\ present\\.\\ \\ inflammatory\\ aneurysm\\ is\\ usually\\ associated\\ with\\ a\\ mantle\\ of\\ perianeurysmal\\ fibrosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aneurysm\\:\\ 0\\.42581798386835\ \(0\)\
\-\ mycotic\\:\\ 0\\.2298856588610886\ \(0\)\
\-\ leaking\\:\\ 0\\.21454037351658928\ \(0\)\
\-\ june\\:\\ 0\\.1753339758734293\ \(0\)\
\-\ approx\\:\\ 0\\.17432488844219068\ \(0\)\
\-\ sepsis\\:\\ 0\\.16663294777766544\ \(0\)\
\-\ inflammatory\\:\\ 0\\.13751141948492923\ \(0\)\
\-\ infrarenal\\:\\ 0\\.12446290079897307\ \(0\)\
\-\ the\\:\\ 0\\.12173406093245864\ \(0\)\
\-\ region\\:\\ 0\\.1216417545250862\ \(0\)\
\-\ suv\\:\\ 0\\.12069629600382444\ \(0\)\
\-\ scan\\:\\ 0\\.12065221630358014\ \(0\)\
\-\ with\\:\\ 0\\.11946226744638615\ \(0\)\
\-\ metabolism\\:\\ 0\\.11621659229479378\ \(0\)\
\-\ 18\\:\\ 0\\.11557628123330903\ \(0\)\
\-\ july\\:\\ 0\\.11556833556080763\ \(0\)\
\-\ in\\:\\ 0\\.11382700855945976\ \(0\)\
\-\ of\\:\\ 0\\.10944168711055059\ \(0\)\
\-\ 15\\:\\ 0\\.10306456420535008\ \(0\)\
\-\ intense\\:\\ 0\\.09598546649118041\ \(0\)\
\-\ pet\\:\\ 0\\.09417118023497813\ \(0\)\
\-\ sigmoid\\:\\ 0\\.09417118023497813\ \(0\)\
\-\ for\\:\\ 0\\.09245603852310685\ \(0\)\
\-\ injection\\:\\ 0\\.08847729620942132\ \(0\)\
\-\ discharged\\:\\ 0\\.08726606916501783\ \(0\)\
\-\ abdominal\\:\\ 0\\.08341791556250402\ \(0\)\
\-\ aorta\\:\\ 0\\.08259941235638336\ \(0\)\
\-\ hawkeye\\:\\ 0\\.0813048923736767\ \(0\)\
\-\ flourodeoxyglucose\\:\\ 0\\.0813048923736767\ \(0\)\
\-\ perianeurysmal\\:\\ 0\\.0813048923736767\ \(0\)\
\-\ were\\:\\ 0\\.07862029544386939\ \(0\)\
\-\ aortic\\:\\ 0\\.07858184576760914\ \(0\)\
\-\ failure\\:\\ 0\\.07719816983367662\ \(0\)\
\-\ change\\:\\ 0\\.07705085415553935\ \(0\)\
\-\ quantify\\:\\ 0\\.07512718499551568\ \(0\)\
\-\ antibiotics\\:\\ 0\\.07491065440869582\ \(0\)\
\-\ above\\:\\ 0\\.0733542478622712\ \(0\)\
\-\ wbc\\:\\ 0\\.07186796271189493\ \(0\)\
\-\ status\\:\\ 0\\.0709591403247118\ \(0\)\
\-\ indistinctness\\:\\ 0\\.07013958253672584\ \(0\)\
\-\ readmitted\\:\\ 0\\.06894947761735469\ \(0\)\
\-\ mantle\\:\\ 0\\.06789973068221049\ \(0\)\
\-\ manage\\:\\ 0\\.06696070005033171\ \(0\)\
\-\ camera\\:\\ 0\\.06611124351713861\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.06462236600263745\ \(0\)\
\-\ autologous\\:\\ 0\\.06462236600263745\ \(0\)\
\-\ staph\\:\\ 0\\.06462236600263745\ \(0\)\
\-\ aaa\\:\\ 0\\.0633469728936791\ \(0\)\
\-\ and\\:\\ 0\\.06303329655573499\ \(0\)\
\-\ wbcs\\:\\ 0\\.06172202330404948\ \(0\)\
\-\ infection\\:\\ 0\\.061421105540878804\ \(0\)\
\-\ following\\:\\ 0\\.06099883310594918\ \(0\)\
\-\ performed\\:\\ 0\\.060154711681262824\ \(0\)\
\-\ sedimentation\\:\\ 0\\.05953735768033586\ \(0\)\
\-\ medically\\:\\ 0\\.05915804308254108\ \(0\)\
\-\ know\\:\\ 0\\.05915804308254108\ \(0\)\
\-\ neither\\:\\ 0\\.05915804308254108\ \(0\)\
\-\ markers\\:\\ 0\\.05879421510514773\ \(0\)\
\-\ aureus\\:\\ 0\\.05879421510514773\ \(0\)\
\-\ cm\\:\\ 0\\.058396454679520406\ \(0\)\
\-\ spect\\:\\ 0\\.05810829614739689\ \(0\)\
\-\ ct\\:\\ 0\\.05806627053348573\ \(0\)\
\-\ decision\\:\\ 0\\.057784167780403815\ \(0\)\
\-\ planar\\:\\ 0\\.057169265515518104\ \(0\)\
\-\ post\\:\\ 0\\.055327785339068604\ \(0\)\
\-\ fdg\\:\\ 0\\.05506243923198312\ \(0\)\
\-\ increased\\:\\ 0\\.054984158396959686\ \(0\)\
\-\ fusiform\\:\\ 0\\.054830931467823835\ \(0\)\
\-\ associated\\:\\ 0\\.05359342294923789\ \(0\)\
\-\ imaging\\:\\ 0\\.05343671780286454\ \(0\)\
\-\ whole\\:\\ 0\\.053359650302174856\ \(0\)\
\-\ was\\:\\ 0\\.05315516443540787\ \(0\)\
\-\ present\\:\\ 0\\.05217573688456479\ \(0\)\
\-\ planned\\:\\ 0\\.05209718329816328\ \(0\)\
\-\ configuration\\:\\ 0\\.051293707337111145\ \(0\)\
\-\ to\\:\\ 0\\.05084001603561613\ \(0\)\
\-\ combined\\:\\ 0\\.05041635548287166\ \(0\)\
\-\ but\\:\\ 0\\.050281329819022565\ \(0\)\
\-\ patient\\:\\ 0\\.049607504745698236\ \(0\)\
\-\ after\\:\\ 0\\.04932703796310421\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.049002780570334116\ \(0\)\
\-\ representing\\:\\ 0\\.04809947162073846\ \(0\)\
\-\ cultures\\:\\ 0\\.04788725807614154\ \(0\)\
\-\ possibly\\:\\ 0\\.04778301656269852\ \(0\)\
\-\ surgically\\:\\ 0\\.04718194292401385\ \(0\)\
\-\ protein\\:\\ 0\\.04718194292401385\ \(0\)\
\-\ images\\:\\ 0\\.04703415389935108\ \(0\)\
\-\ assess\\:\\ 0\\.046990267842016875\ \(0\)\
\-\ response\\:\\ 0\\.04689595428679914\ \(0\)\
\-\ has\\:\\ 0\\.046444840869029114\ \(0\)\
\-\ intravenous\\:\\ 0\\.046350117549485606\ \(0\)\
\-\ serum\\:\\ 0\\.0455893438156326\ \(0\)\
\-\ stranding\\:\\ 0\\.04550868672399244\ \(0\)\
\-\ highly\\:\\ 0\\.04550868672399244\ \(0\)\
\-\ suspicious\\:\\ 0\\.045428753024081794\ \(0\)\
\-\ improved\\:\\ 0\\.04511599995895013\ \(0\)\
\-\ rather\\:\\ 0\\.04503949693301023\ \(0\)\
\-\ fevers\\:\\ 0\\.04488843318437465\ \(0\)\
\-\ repeat\\:\\ 0\\.044593776669213665\ \(0\)\
\-\ radiotracer\\:\\ 0\\.044379006088937606\ \(0\)\
\-\ mental\\:\\ 0\\.04430855079872444\ \(0\)\
\-\ decrease\\:\\ 0\\.04369832826500351\ \(0\)\
\-\ fusion\\:\\ 0\\.0427070244756611\ \(0\)\
\-\ fibrosis\\:\\ 0\\.042590518923865714\ \(0\)\
\-\ either\\:\\ 0\\.04202979644770526\ \(0\)\
\-\ additionally\\:\\ 0\\.041868235266061656\ \(0\)\
\-\ is\\:\\ 0\\.04176897958367941\ \(0\)\
\-\ intermittent\\:\\ 0\\.04155364209608222\ \(0\)\
\-\ measures\\:\\ 0\\.041451197890035846\ \(0\)\
\-\ addition\\:\\ 0\\.0411507464801333\ \(0\)\
\-\ etiology\\:\\ 0\\.04095592893546106\ \(0\)\
\-\ condition\\:\\ 0\\.04062492094805805\ \(0\)\
\-\ same\\:\\ 0\\.04021664126855038\ \(0\)\
\-\ additional\\:\\ 0\\.039411636437471594\ \(0\)\
\-\ made\\:\\ 0\\.03921134603552051\ \(0\)\
\-\ partial\\:\\ 0\\.03917182247718591\ \(0\)\
\-\ uptake\\:\\ 0\\.039093297319008506\ \(0\)\
\-\ hours\\:\\ 0\\.038748252378701095\ \(0\)\
\-\ similar\\:\\ 0\\.038748252378701095\ \(0\)\
\-\ rate\\:\\ 0\\.038525427077769674\ \(0\)\
\-\ at\\:\\ 0\\.03840613711351652\ \(0\)\
\-\ hospital\\:\\ 0\\.03755344798766898\ \(0\)\
\-\ confirmed\\:\\ 0\\.03748791425271196\ \(0\)\
\-\ based\\:\\ 0\\.03682742340863933\ \(0\)\
\-\ involvement\\:\\ 0\\.0367971600593625\ \(0\)\
\-\ early\\:\\ 0\\.0366473658140121\ \(0\)\
\-\ iv\\:\\ 0\\.03632642106834188\ \(0\)\
\-\ intensity\\:\\ 0\\.03610005848057305\ \(0\)\
\-\ extension\\:\\ 0\\.035988997257792955\ \(0\)\
\-\ would\\:\\ 0\\.035988997257792955\ \(0\)\
\-\ heart\\:\\ 0\\.03535021306139999\ \(0\)\
\-\ now\\:\\ 0\\.03489948258157743\ \(0\)\
\-\ contributory\\:\\ 0\\.0347541660830514\ \(0\)\
\-\ unremarkable\\:\\ 0\\.0340833855925037\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.03403893389038938\ \(0\)\
\-\ surrounding\\:\\ 0\\.0339068937301899\ \(0\)\
\-\ positive\\:\\ 0\\.03350122272852862\ \(0\)\
\-\ body\\:\\ 0\\.033459575233124726\ \(0\)\
\-\ resection\\:\\ 0\\.032589367706160416\ \(0\)\
\-\ image\\:\\ 0\\.03251431422853607\ \(0\)\
\-\ show\\:\\ 0\\.032274665620107945\ \(0\)\
\-\ usually\\:\\ 0\\.03200592522614061\ \(0\)\
\-\ diffuse\\:\\ 0\\.03188323334838864\ \(0\)\
\-\ renal\\:\\ 0\\.03165976335522224\ \(0\)\
\-\ fat\\:\\ 0\\.031625875299951485\ \(0\)\
\-\ wall\\:\\ 0\\.03092681237382452\ \(0\)\
\-\ level\\:\\ 0\\.030710552770439402\ \(0\)\
\-\ appearance\\:\\ 0\\.03064971603047832\ \(0\)\
\-\ weeks\\:\\ 0\\.030469658435851095\ \(0\)\
\-\ carcinoma\\:\\ 0\\.03041043863127155\ \(0\)\
\-\ likely\\:\\ 0\\.030380975636510987\ \(0\)\
\-\ time\\:\\ 0\\.030134396341240814\ \(0\)\
\-\ blood\\:\\ 0\\.029526172643770304\ \(0\)\
\-\ than\\:\\ 0\\.02881998609028954\ \(0\)\
\-\ who\\:\\ 0\\.028758477579780478\ \(0\)\
\-\ more\\:\\ 0\\.02791682586782671\ \(0\)\
\-\ symptoms\\:\\ 0\\.027816995415002578\ \(0\)\
\-\ noted\\:\\ 0\\.026955513854846697\ \(0\)\
\-\ tumor\\:\\ 0\\.026592487041353256\ \(0\)\
\-\ it\\:\\ 0\\.026024498104621846\ \(0\)\
\-\ findings\\:\\ 0\\.025091784268895686\ \(0\)\
\-\ which\\:\\ 0\\.023117642765774393\ \(0\)\
\-\ that\\:\\ 0\\.02206283373186214\ \(0\)\
\-\ be\\:\\ 0\\.020623924078806744\ \(0\)\
\-\ as\\:\\ 0\\.0204243992516043\ \(0\)\
\-\ from\\:\\ 0\\.020191657626493262\ \(0\)\
\-\ history\\:\\ 0\\.019423981909211147\ \(0\)\
\-\ or\\:\\ 0\\.017686475268315238\ \(0\)\
\-\ on\\:\\ 0\\.015354678142470306\ \(0\)\
